Assoc. Prof. Dr. Özlem Köroğlu is a specialist in Physical Medicine and Rehabilitation at Memorial Ankara Hospital (2024–present). She previously served as a faculty member at Gaziler Physical Therapy and Rehabilitation Training and Research Hospital (2016–2024). She was Chief of the Physical Medicine and Rehabilitation Clinic at Elazığ Military Hospital (2011–2015). She earned her MD in 2003 from the GATA Faculty of Medicine. She completed her PM&R residency in 2011.
Her credentials include Ministry of Health–approved certified prolotherapy training. She has taught Prolotherapy and PRP (2022) and Knee Prolotherapy and Campinject (2019). She also taught GETAT and Dextrose Prolotherapy (2018) and ISPRM Ultrasound (2009). She has additional training in musculoskeletal ultrasound, neural therapy, lumbar injections and manipulation, and botulinum toxin treatment for the spastic hand. She attended the Euro‑Mediterranean PRM School in Italy (2010). She is a member of the Turkish Society of PM&R, the Turkish Society for Research and Fight Against Rheumatism, the Association of PM&R Specialists of Türkiye, the Spinal Cord Diseases Association, and the Ankara Medical Chamber.
Présenté deux fois à la télévision nationale en tant qu'expert en urologie, le Dr Lee Chun Yong est spécialisé dans les troubles des calculs urinaires et les affections de la prostate à l'hôpital Naeun.
Reconnu internationalement pour ses traitements de neuromodulation et de neurostimulation, le Dr Castaño est spécialisé dans les dysfonctionnements du bas appareil urinaire à la clinique universitaire CES.
Le professeur associé Cem Basatac est spécialisé dans les procédures d'urologie laparoscopique mini-invasive à l'hôpital Gayrettepe Florence Nightingale.
Urologiste, chirurgien
Le Prof. Dr Eduard Becht est spécialisé dans les opérations de tumeurs rénales avec conservation de l'organe et les techniques d'urologie mini-invasives à la Clinique Nordwest.
Spécialisé dans les procédures urologiques mini-invasives aux hôpitaux Büyük Anadolu, se concentrant sur les maladies de la prostate et les affections des voies urinaires.
Spécialisé en RIRS (fragmentation des calculs rénaux au laser) – une technique précise et mini-invasive pour les calculs rénaux – aux hôpitaux Büyük Anadolu.
Le professeur Yurdakul a été formé à la Cleveland Clinic en uro-oncologie – spécialisé dans les prostatectomies avec préservation nerveuse et les cas complexes d'infertilité masculine au Medical Park Göztepe.
Spécialiste en onco-urologie avec un fort accent sur la prostatectomie robotisée da Vinci au centre médical Assuta.
Spécialisé dans la prostatectomie robotisée da Vinci – une technique précise et mini-invasive au centre médical Rambam.
Chef du service d'urologie au centre médical Rambam, Gilad Amiel est spécialisé en oncologie urologique chirurgicale et dans les cas complexes de prostate.
Le Dr Vladimir Yutkin combine plus de 20 ans d'expertise en urologie avec des connaissances spécialisées dans les troubles de l'articulation temporo-mandibulaire au centre médical Hadassah.
Le professeur Gofrit dirige le service d'urologie du centre médical Hadassah et est qualifié pour effectuer des chirurgies robotiques avec le système da Vinci.
Le professeur Arie Lindner dirige le service d'urologie du centre médical Assaf Harofeh, se spécialisant dans les interventions complexes de la prostate, y compris les traitements au laser.
Le Prof. Serkan Deveci est un expert de premier plan en urologie au Medical Park Göztepe, avec plus de 20 ans d'expérience et plus de 600 citations dans la recherche en urologie.
Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.
He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.
Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).
Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.
He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.
Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.